Trial
NCT02365233
Fatty Liver Study in Patients With Type II Diabetes
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Medical Branch, Galveston
Collaborators
—
Condition
Type II Diabetes
Intervention
DPP4 inhibitor
Why stopped
IRB withheld the data due to inadequate supporting documentation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-31